| Not Yet Recruiting | Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Tw RSV Immunization | Phase 3 | 2025-09-01 |
| Recruiting | Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV Respiratory Syncytial Virus (RSV) | Phase 2 | 2025-07-16 |
| Withdrawn | Evaluation of the Prevalence of E. Coli O Serotypes in Paediatric Population With Recurrent Urinary Tract Infe Urinary Tract Infections | — | 2025-03-11 |
| Withdrawn | Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV HIV Infections | Phase 1 / Phase 2 | 2025-02-01 |
| Completed | UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children HIV Infection | Phase 2 | 2024-12-11 |
| Recruiting | Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among Infection, Bacterial, Infection Prevention | N/A | 2024-05-28 |
| Unknown | Mpox Paediatric and Adolescent Clinical Study Monkey Pox, Monkeypox | — | 2023-03-17 |
| Active Not Recruiting | Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who A HIV Infections With Multi Drug Resistant Virus | Phase 1 / Phase 2 | 2022-06-30 |
| Active Not Recruiting | DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection HIV Infections | Phase 2 / Phase 3 | 2022-04-22 |
| Completed | Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emerge Community-acquired Acute Lower Respiratory Infection | N/A | 2021-07-07 |
| Completed | European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Sars-Cov2 Antibodies in Children and Adolescents Living With HIV | — | 2020-10-14 |
| Completed | Early Anti-Retroviral Treatment in HIV- Infected Children HIV Infections | — | 2018-05-01 |
| Terminated | Neonatal Vancomycin Trial Late Onset Neonatal Sepsis | Phase 2 | 2017-02-27 |
| Completed | ODYSSEY (PENTA 20) HIV Infection | Phase 2 / Phase 3 | 2016-09-20 |
| Completed | Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Childre HIV Infection | Phase 2 / Phase 3 | 2016-06-01 |
| Completed | Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningiti Meningitis | Phase 1 / Phase 2 | 2013-02-01 |
| Unknown | European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol HIV Infections, Tuberculosis Infection, Hepatitis C | — | 2013-01-01 |
| Completed | Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-on Sepsis | Phase 3 | 2012-09-01 |
| Unknown | BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infectio HIV | Phase 2 / Phase 3 | 2011-04-01 |
| Completed | KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Vers Antiretroviral Therapy in HIV-1 Infected Children | Phase 2 / Phase 3 | 2010-08-01 |
| Completed | PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Mo HIV Infection | Phase 1 | 2006-07-01 |
| Completed | Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combina HIV Infection | Phase 1 | 2003-01-01 |